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CHARACTERIZATION OF THE INHIBITION OF CELLULAR 
DNA SYNTHESIS BY REOVIRUS ADENINE-RICH RNA
CHAPTER I 
INTRODUCTION
The sequence of events affecting a eukaryotic cell 
emerging from a division up to the end of the following 
division is called the cell cycle. The cell cycle consists 
of four phases: G^, first gap; S, synthesis; G 2 , second gap;
and M, mitosis phase. During the S phase, the deoxyribonu­
cleic acid (DNA) is replicated by a semiconservative mechanism. 
The chromosome is duplicated in a specific order (67) and the 
"Satellite" DNA's situated near the centromere of the chromo­
some are replicated last (25,68). Replication is initiated at 
the center of a replication unit and chain growth proceeds 
bidirectionally toward outlying termini where the newly 
replicated chains fuse with those synthesized in adjacent 
regions of DNA. At the completion of the S-phase of the cell 
cycle, long progeny DNA molecules, characteristic of the 
eukaryotic chromosome, have been synthesized (35,36). It has 
also been demonstrated both in bacterial and mammalian cells 
that initiation of DNA starts with the synthesis of an RNA
priming fragment by DNA-dependent RNA polymerase and the 
fragment is then extended by the DNA polymerase. The RNA 
primer fragment is later recognized and excised, possibly by 
the exonuclease activity of the DNA polymerase I (42). Studies 
of the initiation and termination of RNA primer and DNA chain 
elongation have not provided sufficient information to charac­
terize the control of these processes and the enzymes involved.
In mouse L-cells, functioning initiation sites for DNA 
synthesis are distributed in clusters. The modal interval 
between individual sites is 40 to 50 ym (33) . Infection with 
reovirus results in inhibition of cellular DNA synthesis in 
6 - 8 h after infection and before the onset of cytopathologic 
effects (23,28,30,31). In infected cells the distance between 
initiation sites is increased (33), and in synchronized L-cells 
the initiation of the synthetic phase is completely inhibited 
in cells infected 8 h before the beginning of DNA synthesis 
(19). These observations make this cell-virus system a pro­
mising model to elucidate cellular DNA replicative control 
mechanisms.
The physical characteristics and the replication of the 
reovirion has been studied in detail. The reovirion has icosa- 
hedral symmetry and possesses two capsid shells composed of pro­
teins. The outer shell proteins can be completely hydrolyzed by 
chymotrypsin leaving the inner reovirus shell intact, which is 
known as the core (57,64 ). The genome of reovirions consists 
of double stranded (ds) ribonucleic acid (RNA) having a molecular 
weight of 15 x 10^ daltons per virion (29). It has been
established that the genome RNA consists of a heterogeneous 
population of 10 distinct ds-RNA fragments; three large, three 
medium and four small, with approximate molecular weights of 
2.5 X  10^, 1.4 X  10^ and 0.8 x 10^ daltons respectively (11,55, 
59,70,72,74). Sequences of the 5 '  and 3 '  termini of genome 
RNA segments have been reported to be (p)ppGpPyp- and 
-pPypApApC^jj (p = phosphate, Py = Pyrimidine) respectively 
(1,2). This strongly indicates that the ds-RNA segments are 
perfect duplexes which arise as the result of independent syn­
thetic processes (1,2,3). Recently it has been reported that 
both m-RNA and the corresponding plus strand in the genome 
RNA contain a blocked and methylated 5 '  terminus of the structure 
m^G(5")ppp(5")G"'pCp— (16,27) .
Reovirions also contain, in addition to the genome 
ds-RNA, single-stranded (ss) RNA of low molecular weight, 
which comprises up to 25-50% of the total amount of RNA in 
reovirions. The ss-RNA is rich in adenine nucleotides, and 
is referred to as adenine-rich (A-rich) RNA (8,41,58,65).
The ss-oligoribonucleotides are 2-20 nucleotides long and are 
present in the central virion cavity. These oligonucleotides 
are lost when the outer capsid shell is degraded (6,7,38).
The ss-oligonucleotides have been fractionated by DEAE-cellu- 
lose column chromotography and two-dimensional electrophoresis 
(10,48,65). Chromotography separated the oligonucleotides 
into two classes of molecules: (1 ) a series of molecules in
which the only nucleotide is adenylic acid. These molecules
range in length from 2 - 2 0  nucleotides and have either ppp, 
pp or p at their 5 '  termini, and can be represented by the 
formula (p)(p)p(A)^_^gAgQ. There as about 850 such molecules 
present in each virion and they account for some 55% of the 
total oligonucleotides. This class is referred as the reovirus 
oligoadenylates (10,48,65); (2) the second series of oligonu­
cleotides with sequences (p)ppGCQ^ , (pjppGCU^^ , (p)ppGCUAQy , 
(p)ppGCUA(A) , and (p) ppGCUA(U) , are called the
reovirus 5 '  -G-terminated oligonucleotides. This fraction of 
ss-oligonucleotides will be referred in this dissertation as 
heterologous oligonucleotides. There are approximately 2000 
of these molecules in each virion. In addition there are 
some 350 other molecules from 2-8 nucleotides long (approxi­
mately 1 0 % of the total) for which the sequences have not been 
determined. In total there are 3200 oligonucleotide molecules 
having a total molecular weight of 4-5 x 10® daltons in each 
reovirion. It has been proposed that these oligonucleotides 
are the products of abortive transcription by the enzyme RNA- 
transcriptase during the final stages of morphogensis of 
progeny virions (10,48). Recently, oligo(A) polymerase activity 
has been identified in reovirions. The enzyme catalyzes 
in vitro synthesis of oligo-A similar in size to that in 
virions by a primer-independent mechanism (14,61). Oligonu­
cleotides are not found free in the cells, but are always 
associated with viral and subviral particles and are synthe­
sized in all reovirus-infected cells (8,58).
In purified reovirions five enzymatic activities have 
been described:
1. The ds-RNA dependent ss-RNA polymerase, the tran­
scriptase, which is a part of the capsid. It is inactive in 
the intact virion, and can be activated by partial removal of 
the outer capsid shell polypeptides (12,51,57). The ss-RNA 
dependent ds-RNA polymerase, the replicase, which is associated 
with subviral particles have been isolated and characterized 
(47,51). However, it has been suggested that the two enzyme 
activities may not be completely autonomous. The replicase 
could conceivably be converted into the transcriptase when the 
enzyme template complex associates with additional protein to 
form the subviral particle.
2. Reovirus cores can catalyze an exchange reaction 
between the four ribonucleoside triphosphates and inorganic 
pyrophosphate (71).
3. Cores also possess a nucleoside triphosphate phos- 
phophydrolase activity which liberates inorganic phosphate 
from all common ribo- and deoxyribonucleoside triphosphates 
(13,40).
4. As described previously, reovirions contain oligo-A 
polymerase activity which is absent in cores. It has been 
suggested that oligo-A polymerase may be an alternative 
activity of the virion bound transcriptase and may be regulated 
by outer capsomere proteins (61).
5. Cores possess m-RNA modifying activities, and 
these are the capping activity and two methylases that result
in the formation of transcripts with blocked, methylated 
5^-ends: m/cpppG^pC (27).
Replication of reovirions begins when they are taken 
into the cell by a process of pinocytosis. The phagocytic 
vacuole then fuses with lysosomes. The outer capsid is 
partially degraded by lysosomal proteases, converting the 
virions into subviral particles (SVP), which are then trans­
ferred to perinuclear regions of the cell. In this area they 
appear as cytoplasmic inclusions and are referred to as 
"factories" which are the sites of accumulation of progeny 
viral RNA and proteins (20,63). Reovirus genome RNA is not 
uncoated, but remains within the SVP throughout the multi­
plication cycle (15,62). Partial degradation of the outer 
capsid shell results in full transcriptase activity of the 
SVP (15,45). Transcription leads to the production of two 
classes of m-RNA, defined according to the time of synthesis 
and the nature of the particle which synthesizes them during 
the infectious cycle. These are the early and late m-RNA's 
produced by the parental SVP and the progeny immature virus 
particles (9,50). Both early and late m-RNA's are transcribed 
by the virion associated transcriptase (37,73,75). The same 
enzyme has been proposed to be responsible for the synthesis 
of reovirus A-rich RNA, a component of the virion. The A-rich 
RNA is produced between 9 and 13 h after infection of L-cells 
(8 ). It is of interest to note that the first appearance of 
A-rich RNA coincides with the start of the inhibition of 
cellular DNA synthesis in the infected cells. The rate of
total protein synthesis does not decrease for several hours 
following infection (22,28,43). Reovirus specified proteins 
are synthesized very slowly during the early period of 
infection, but when the rate of synthesis of late m-RNA 
increases, virus specified protein synthesis predominates 
over host protein synthesis (78).
Since the reovirus genome is not uncoated, the infor­
mation for the synthesis of progeny genome RNA and for viral 
protein synthesis is furnished by plus RNA strand transcripts. 
These plus RNA strands act as m-RNA's early in infection and 
as template for the synthesis of minus strand during later 
stages of infection. The newly synthesized minus strand does 
not separate from the plus stranded template (53). The genome 
ds-RNA is formed sequentially in particles with the S segments 
formed first and the L segments formed last. After the progeny 
genome ds-RNA is formed it serves as a template for late m-RNA 
synthesis (77). The syntheses of ds-RNA and ss-RNA reaches 
maximum levels 6 - 8 h after infection and then declines. Pro­
geny virus is detectable 8 - 1 0  h after infection and in spite 
of severe cytopathic effects, most of the progeny virions 
remain cell associated (39) .
As mentioned previously, infection of L-cells with 
reovirus brings about inhibition of cellular DNA synthesis 
6 - 8 h after infection and at this time no cytopathology is 
observed (18,28). Experimental results indicated that initia­
tion of synthesis of DNA upon new regions of chromosomal DNA 
replication is blocked (23,28,31,33), but reovirus infection
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does not alter DNA chain growth (31). It may be postulated 
that the DNA inhibition observed could be the result of reduced 
activity of DNA synthesizing enzymes. However, no decrease in 
DNA synthesizing enzymes was found at 12 h post infection, a 
time when cellular DNA synthesis is 90% inhibited (23,60). 
Bartkoski has reported that neither the concentration nor 
activities of nuclear and cytoplasmic DNA polymerases were 
altered significantly at times after inhibition of DNA synthe­
sis in reovirus infected cells. Also when nuclei, chromatin 
or hypotonically swollen cells were assayed for ^  vitro DNA 
synthesis, no difference was seen between infected and unin­
fected cells (4). The DNA inhibition is not due to degrada­
tion of host DNA or due to inactivation of DNA (at least 
in vitro), or loss of efficiency as a template or ^  vitro DNA 
synthesis, because these functions were unaltered when tested 
in vitro (4,23,30). It has also been shown that decreased 
thymidine incorporation in the infected cells represents a real 
decrease in DNA synthesis (24,60), and that DNA inhibition is 
not the result of depletion of precursor molecules (23,30,60).
Since infection causes an early decrease in DNA synthe­
sis without concomittant decrease in total protein synthesis 
(22,28,60,78), this information suggests the action of reovirus 
on DNA replication may be direct and specific for one or more 
functions associated with initiation events for DNA replication.
The inhibition of initiation of DNA synthesis is a 
phenomenon observed in L-cells, which is a transformed cell
line. Duncan (21) has recently reported similar inhibition 
of DNA synthesis in transformed human diploid WI-38 cells.
But no such inhibition was seen in the infected normal WI-38 
cells. No cytopathic effects were observed up to 14 days 
post-infection while the cells appeared to be persistently 
infected by the virus (21). These observations indicate a 
selective recognition and inhibition of DNA synthetic mecha­
nisms of only the transformed cells, by reovirus components 
and/or replication products.
The inhibition of DNA synthesis is a dose-dependent 
phenomenon (18). Using a multiplicity of infection of 1000 
plaque-forming-units per cell, the inhibition of DNA synthe­
sis began 2-4 h after infection and the initial rate of inhibi­
tion increased. Reovirus irradiated with ultraviolet light 
sufficient to abolish infectivity but not transcriptase 
activity, inhibits DNA replication in L-cells as efficiently 
as infectious virus (18,60). This suggests that either a 
component of the virion is capable of causing the inhibition 
or that the RNA genome may remain partially functional after 
UV-irradiation and give rise to an inhibitory component. A 
limited amount of viral RNA is transcribed in cells infected 
with UV-irradiated virus and it has been suggested that it 
may be the A-rich RNA (32).
However, we can not exclude the possibility that viral 
capsid proteins may also be inhibitory for DNA synthesis. 
Reovirus empty capsids (top-component) devoid of ds-RNA and
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A-rich RNA can be easily separated from the virion by cesium 
chloride density gradient centrifugation. Reovirus top- 
component had no inhibitory effect on cell RNA, protein or DNA 
synthesis even at doses as high as 5000 particles per cell 
(17,32,44). This again suggested that A-rich RNA or genome 
ds-RNA might be responsible for inhibition of DNA synthesis. 
Another incomplete particle, the infectious subviral particle 
(SVP^) can be obtained by limited chymotrypsin treatment of 
reovirions (38). This enzyme treatment results in the partial 
loss of the outer capsid polypeptides and 60% of the A-rich 
RNA, but has the full complement of genome ds-RNA. The SVP^ 
produced a delayed inhibition of DNA synthesis (17). Since 
A-rich RNA is the only virion nucleic acid released early in 
infection, these observations suggest that A-rich RNA may be 
the viral component capable of mediating DNA inhibition in 
L-cells. This supposition is also substantiated by an earlier 
report by Clinkscales (17) that reovirus cores, which have 
lost all of the A-rich RNA complement, do not inhibit DNA 
synthesis in L-cells.
It was found that reovirus A-rich RNA was capable of 
mediating a selective inhibition of cellular DNA synthesis 
(46). Inhibition began 3-4 h after treatment with A-rich RNA 
(1 yg/ml). However, this inhibition was transitory and cellu­
lar DNA synthesis returned to control levels in 9-10 h after 
infection
Reovirus A-rich RNA is the only single virion component 
tested which inhibits cellular DNA synthesis (32,46). Two
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hypotheses can be suggested which are consistent with the 
inhibitory role of A-rich RNA during reovirus infection: 
first, the increased efficiency of inhibition resulting from 
high input multiplicities may be the result of the release of 
increased amounts of an input virion component, i.e. the 
A-rich RNA; and second, that the increased input multiplicity 
results in higher yields of progeny virions and A-rich RNA 
which in turn mediates increased efficiency of inhibition.
To investigate these possibilities two types of experiments 
were conducted.
1. Cells were treated with a range of high doses of 
purified reovirus A-rich RNA. The objective of such experi­
ments was to determine if higher doses of A-rich RNA could 
mediate an increased rate and magnitude of inhibition of DNA 
synthesis.
2. Cells were treated with a selected range of 
nucleotide doses of A-rich RNA at various time intervals. 
Hopefully this would simulate the conditions of natural virus 
infection whereby a constant amount of A-rich RNA is synthe­
sized by the progeny SVP causing a sustained inhibition of 
DNA synthesis.
Earlier work indicated that synthetic polyadenylic 
acid having the same molecular weight as reovirus A-rich 
RNA had no effect on the inhibition of cellular macromolecular 
synthesis (46). This suggests that the heterologous oligonu­
cleotide fraction (5"-G-terminated oligonucleotide) of the
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A-rich RNA may be the inhibitory component and that the oligo- 
adenylate fraction has no effect on cellular macromolecular 
synthesis. To test this hypothesis experiments were conducted 
with endo- and exoribonuclease-treated reovirus A-rich RNA in 
order to selectively abolish the inhibitory activity o f . 
specific A-rich RNA fractions. Thus, this dissertation 
attempts to further characterize the selective modification 




Cells. Mouse fibroblasts, strain L-929 (52) (Flow 
Laboratories), adapted for growth in spinner culture, were 
used in all experiments. Stock cultures of L cells were 
maintained in minimal essential medium for spinner culture 
(MEM) (Grand Island Biological Supply Company) supplemented 
with 5% (v/v) heat inactivited fetal calf serum (PCS, Grand 
Island Biological Company). Cells were maintained in loga­
rithmic growth at cell densities from 5.0 x 10^ cells/ml to 
2.0 X  10^ cells/ml by dilution every 48 h with fresh, pre­
warmed growth medium.
Asynchronous growth conditions. Cells to be used in 
experiments that required higher cell densities than the 
stock culture were maintained as asynchronous cultures by 
centrifuging the cells from growth medium at 250 x g for 
5 min, and resuspending them in fresh, pre-warmed growth 
medium at 48 h intervals.
Determination of Cell Viability. Cell viability at 
times after treatment was determined by trypan blue exclu­
sion (49,54). Non viable cells were those that stained blue.
At timed intervals growth medium was removed from the treated
13
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monolayers, and the cell sheet washed twice with 5 ml MEM
(no serum) to remove all serum. Then 2 ml of MEM (no serum)
and 0.2 ml of a 0.4% (w/v) trypan blue solution was added to
the flask. Incubation was for 5 min at 37 C. The solution
was removed and the cell sheet examined by light microscopy.
Cells which excluded trypan blue and thus were unstained were
considered viable. Total cells and cells stained blue were
counted in ten random fields to determine percent viability.
Virus. Reovirus type 3, kindly provided by Dr. P . J .
Gomatos, was used in the study. Plaque-purified virus was
prepared by picking a large, well isolated plaque from an
infected L cell monolayer. The agar plug, picked with a
small pipette, was transferred to 1 ml of sterile 0.15 M
sodium chloride, 0.015 M sodium citrate, pH 7.5 (SSC) and
maintained at 4 C for 24 h. Virus eluant in SSC was then
2pipetted onto one confluent L-cell monolayer (25 cm surface)
from which the medium had been removed. One hour was allowed
for virus adsorption and the SSC was replaced with fresh,
prewarmed growth medium. After incubation at 37 C for 36 h, the
infected cells were sonicated and the resulting first-passage
2lysate was used to infect 10 large monolayers (75 cm surface). 
After a 24 hr incubation these monolayers were sonicated and 
pooled, and the lysate was then titered, and frozen at -20 C 
Virus stocks for purification were prepared by con­
centrating L-cells to 1 X 10^ cells/ml in MEM without serum.
The cells were infected with 10-20 plaque forming units (PEU)/
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cell and allowed to adsorb at 37 C for 1 h. The infected , 
cells were then diluted to 1 x 1 0 ^ cells/ml with growth 
medium. After 24 h incubation at 34 C, the cultures were 
chilled and the infected cells collected by centrifugation 
at 5000 X g for 15 minutes. The pellets were frozen at 
-20C.
Virus purification. Reovirus was purified as 
described by Smith, et al. (64) with modification. All 
centrifugation and extraction was done at 4 C. The organic 
phases from the first three extractions were pooled and 
extracted 2-3 times with an equal volume of homogenizing 
medium. All the aqueous phases were mixed and re-extracted 
twice with freon. The final separated aqueous phase was 
layered onto a 10 ml CsCl density gradient (1.2 g/ml-1.4g/ral) 
in a 38 ml centrifuge tube. This was centrifuged at 4 C 
for 1 h at 76,600xgin the SW 27 rotor using a Beckman L2-50 
preparative ultracentrifuge. The virus banded at a density 
of 1.37 g/ml and the band was collected cleanly with a syringe. 
The CsCl was removed by exhaustive dialysis against cold SSC 
or by pelleting the virus by centrifugation for 1 h at 82,400x 
g in SW 27 rotor. The virus was layered onto a 15 ml 20-40% 
(w/w) glycerol gradient in 0.02 M Tris pH 8.0, which had been 
equilibrated at 4 C for 15-20 h in a 17 ml tube. Centrifuga­
tion was performed for 45 min at 82,500xgin the SW 27.1 rotor. 
The virus band was collected and dialyzed exhaustively against 
cold SSC. This was a purified stock virus suspension and was
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stored at 4 C. On the average 20-30 mg of purified reovirus 
was obtained from 1 liter of infected cells.
Virus assay. Reovirus was assayed on confluent mono­
layers of L-cells as described by Shaw (60). Cells from spinner 
culture were adjusted to a density of 4 x 10^ cells/ml and 
pipetted into small plastic tissue culture plates (60 x 15 
mm, Falcon Plastics) at 2.0 x 10^ - 2.4 x 10^ cells/plate.
The cells were allowed to grow to near-confluency.
Dilutions of reovirus were prepared in MEM (no serum). 
Medium was removed from the monolayers and 0.1 ml of each 
virus dilution was pipetted onto the center of the monolayer.
The plates were incubated for 1 h at 39 C in a humid atmosphere 
of 5% (v/vj CO^ in air to allow for virus adsorption. Five ml 
of autoclavable MEM (Auto Pow, Flow Laboratories), contain­
ing 3% (v/vj FCS, 1% (w/v) agar (Difco Laboratories), and 100 
ug/ml kanamycin was added to the plates and allowed to 
solidify. The plates were incubated at 39 C in an atmosphere 
of 5% (v/v) CO2 in air for 72 h. At this time a second over­
lay containing 0.005% (w/v) neutral red was added. Plaques were 
counted within 24h after addition of the second overlay.
Purification of reovirus adenine-rich RNA. Extraction 
of total RNA from purified reovirus suspended in SSC contain­
ing 0.5% sodium dodecyl sulfate (SDS) was carried out by 
phenol extraction (48) . The procedure is outlined on the 
flow sheet Fig. 1. Phenol-extracted RNA solution was extracted 
with ether to remove residual phenol. The dissolved ether was
17
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Phenol free RNA Sol
I
Lyophilize1Dissolve RNA in Tris-HCl buffer
Chromatograph on a Sephadex G-lOO
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distilled water and lyophilize
Fig. 1. Purification of reovirus adenine-rich RNA.
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evaporated by passing filtered air through the solution and 
the final RNA solution was lyophilized. The lyophilized RNA 
was dissolved in 0.02 M Tris-HCl pH 8.0, and passed through a 
1 cm X  20 cm column of Sephadex G-lOO (Pharmacia) previously 
equilibrated with the same buffer (2,65). The fractions were 
collected with an Isco gradient collector and absorbance was 
monitored at 254 nm with an Isco ultraviolet absorbance moni­
tor. The double-stranded RNA in the void volume and A-rich 
in the included volume were eluted with 0.02 M Tris-HCl buffer, 
pH 8.0, (see Fig. 3 for elution profiles). Both fractions 
were pooled separately and desalted by dialyzing against deion­
ized distilled water. Desalted A-rich RNA solution was 
lyophilized and stored at -20C until used.
Preparation of polyadenylic acid. Synthetic polyadeny- 
lic acid (Miles Lab.) with a minimum molecular weight of greater 
than 1 0 0 , 0 0 0  daltons was subjected to alkaline hydrolysis 
with 0.1 N NaOH for 12 h at room temperature to reduce its 
molecular weight to that approximating the molecular weight 
of reovirus A-rich RNA (4 6 ). The pH of the hydrolyzed poly­
adenylic acid solution was adjusted to 6 . 8 and chromatographed 
on a 1 cm X  100 cm column of Sephadex G-50 (Pharmacia), the
procedure is outlined on the flow sheet Fig. 2. Fractions 
were eluted with 0.1 M phosphate buffer, pH 6 . 8 containing 
0.1% SDS and 0.2 M NaCl, and collected with an Isco gradient 
collector. Purified reovirus A-rich RNA was used as a mole­
cular weight marker and only the included fractions of poly­
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Chromatograph on a desalting 
Sephadex G-10 1x50 cm column
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Lyophilize
Fig. 2. Preparation of synthetic polyadenylic acid.
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fractions as reovirus A-rich RNA (Fig. 4). The fractions 
were pooled and SDS was removed by extracting 5 X with equal 
volumes of n-butanol and the solution was lyophilized (48). 
Dried material was desalted by passing it through a 1 cm x 
40 cm Sephadex G-10 column. The final salt free fractions in 
distilled water were pooled and lyophilized (Fig. 2). Auto- 
claved deionized distilled was used in the desalting column 
chromatography.
Quantitation of RNA. RNA in the reovirus A-rich RNA 
and polyadenylic acid preparations was determined by the 
orcinol test (56) using yeast RNA as a standard.
Determination of macromolecular synthesis. Cells in 
spinner cultures were adapted to 10% FCS for 1-2 weeks before 
making monolayers. Plastic tissue culture flasks (30 ml)
5were inoculated with 7 x 10 cells/flask in 6 ml MEM 
supplemented with 10% (v/v) FCS. The flasks were incubated 
in a CO^ incubator for 20 h. During this time they formed 
semi confluent monolayers. The old medium was removed and 
fresh pre warmed MEM (no Serum) was then added (2 ml/flask). 
Monolayer cultures were treated with 1.0, 2.0 and 5.0 yg/ml of 
reovirus A-rich RNA or polyadenylic acid in 0.01 M Tris-HCl 
buffer pH 7.2 containing 4% (w/v) Sucrose. The RNA was 
allowed to adsorb for 2 h in CO^ incubator and then the 
medium was reconstituted with 10% (v/v) FCS. Control flasks 
were treated with the same volume of buffer. At timed 
intervals duplicate treated and control flask were pulse
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3 3labelled for 30 min with 0.5 yCi/ml of H-thymidine, H-uridine
3or H-L-amino acids mixture for DNA, RNA and protein synthesis 
respectively. At the end of the labelling period, the reaction 
was stopped by removing the medium and the cell sheet was 
washed 2 x with 2.0 ml of ice cold MEM (no serum). Then 
2 ml of cold 5% (w/v) trichloroacetic acid (TCA) was added 
and the monolayers were sonicated and stored at 4 C for at 
least 1 h for precipitation. The acid-insoluble precipitate 
was collected on millipore filters (pore size 1.2 y). The 
filters were washed 3 x with 2 ml of cold 5% TCA to remove 
unincorporated radioactivity and dried by washing with 2 ml 
of 95% ethanol. The radioactivity was counted in a Beckman 
DPM-100 liquid scintillation spectrophotometer after 
dissolving the filters in 10 ml of Beckman Cocktail D 
(5 g diphenyloxazole, 100 g naphthalene, 10 ml water, dissolved 
in p-dioxane to make 1 liter).
Enzyme assay. The activity of the ribonucleases was 
assayed by using selected concentrations of each enzyme and 
yeast RNA as a substrate. The following procedures were used 
for each assay:
1 - Pancreatic ribonuclease: Worhington enzymes (76).
2 - Ribonuclease T̂, and T^ : Uchida & Eg ami (69).
3 - Ribonuclease Takai et al. (6 6 ).
4 - Snake venom phosphodiesterase was assayed by 
adding 2.5 Mg, 5 Mg, and 10 Mg quantities of the enzyme to 
0.01 M Tris-HCl buffer pH 8.4 containing 0.05 M MgCl2 » The
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reaction mixture was preincubated at 37 C for 4-5 min and 
0.25 ml of a 12 mg/ml yeast RNA solution was added. The 
reaction was allowed to proceed in a water bath at 37 C, and 
stopped after 15 min by adding 0.25 ml of uranyl reagent 
(0.75% uranyl acetate in 25% perchloric acid) making a final 
volume of 1.0 ml. The precipitate was immediately removed by 
centrifugation at 5000 rpm for 10 min at 4 C and 0.2 ml of 
the supernatant solution was diluted with 5.0 ml of auto- 
claved distilled water, and the optical density was read at 
260 nm against a blank incubated without enzyme. If the 
dilution was not performed immediately the blank absorbance 
would increase with time.
Enzymatic hydrolyses of reovirus A-rich RNA. Conditions 
for enzymatic hydrolysis of reovirus adenine-rich RNA were:
Pancreatic ribonuclease-A: 5 ug/ml in 0.05 M Tris-HCl
buffer, pH 8 , containing 0.15 M NaCl, for 30 min (65).
Ribonuclease T ^ : 40 units/ml in 0.2 M Tris-HCl buffer,
pH 7.5, containing 0.005 M ethylenediaminetetra-acetate (EDTA) 
tetrasodium salt for 2 h (65).
Ribonuclease T^: 5 units/ml in 0.1 M sodium acetate
buffer, pH 4.5 for 3 h (8 ).
Venom phosphodiesterase: 4 units/ml (0.2 mg/ml) in
0.01 M Tris-HCl buffer, pH 8.4, containing 0.05 M MgClg for 
1 h (65).
Ribonuclease N̂ :̂ 100 units/mi (88 ug/ml) in 0.2 M
Tris-HCl buffer, pH 7.0 for 3 h (6 6 ).
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In all cases reaction mixtures were incubated at 37 C. 
The hydrolyzed reovirus adenine-rich RNA solutions were 
adjusted to pH 7.2 using sterile 0.1 N HCl or NaOH solutions 
and then diluted to the proper concentration with 0.01 M Tris- 
HCl buffer, pH 7.2, containing 4% (w/v) Sucrose and stored at 
-20 C until assayed for DNA inhibition activity as described 
previously.
Radioisotopes and enzymes. The source and specific 
activity of the radioactively labelled precursors and enzymes 
used in this study are as follows:
New England Nuclear
Uridine (5-^H) 26.4 Ci/m mole 
Thymidine (methyl-^H) 19.9 Ci/m mole 
L-amino acid mixture (^H-general label)
Sigma Chemical Company
Ribonuclease-A from bovine pancrease 
90 Kunitz units/mg protein 
Ribonuclease T^ 240580 units/mg protein 
Ribonuclease T^ 1350 units/mg protein 
Ribonuclease N^ 1140 units/mg protein 
Worthington Biochemical Corporation
Venom phosphodiesterase 20 units/mg dry powder
CHAPTER III
RESULTS
Reovirus adenine-rich RNA preparation. To study
the effects of reovirus A-rich RNA on L-cells, it was 
necessary that the preparation be pure and free of any con­
tamination with genome ds-RNA fragments and to minimize 
degradation by ribonucleases. This was achieved by following 
an established procedure of chromatographic separation of 
A-rich RNA from the genome ds-RNA described by Stoltzfus and 
Banerjee (65 ) . To avoid degradation by contaminating 
ribonucleases, all buffers and solutions were autoclaved to 
destroy the enzymes. Total reovirus RNA was fractionated 
using Sephadex G-100. The elution profile is shown in Fig. 3. 
The ds-RNA eluted in the column void volume fractions 14-24.
The single-stranded A-rich RNA was well separated and eluted 
in fractions 38-60. This elution profile is similar to the 
profile reported by Stoltzfus and Banerjee (65). The fractions 
containing A-rich RNA were pooled, desalted, lyophilized and 
stored at - 2 0 0  until use.
Synthetic polyadenylic acid preparation. We have 
proposed that it is only the heterologous oligonucleotide 
fraction of the reovirus A-rich which is responsible for the
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Figure 3. Sephadex G-100 profile of the fractionation of reovirus RNA. RNA was 
extracted with phenol and chromatographed according to the procedure 
described in Methods and Materials. The flow rate was approximately 













D S - R N A0.8-
0 6-
0-4-
A _ R I C H  RNA
0 2 -
0 0
1 c) :2C) 3(D /!(] 550 (5(D /̂C) 8 C)
K)
F R A C T I O N  N U M B E R
27
inhibition of DNA synthesis and that the oligoadenylic acid 
fraction has no effect on cellular DNA synthesis. An indirect 
approach was used to test this hypothesis. A preparation of 
synthetic polyadenylic with a molecular weight similar to 
A-rich RNA was prepared in order to study its effects on the 
synthesis of cellular macromolecules. Synthetic polyadenylic 
acid (poly-A) with a minimum molecular weight of greater than 
1 0 0 , 0 0 0  daltons was hydrolyzed with alkali to reduce it to a 
molecular weight similar to A-rich RNA. The hydrolyzed sample 
was chromatographed on a Sephadex G-50 column to separate the 
fractions having molecular weight similar to A-rich RNA. Reo­
virus ds-RNA and A-rich RNA were used as markers in separate 
calibration runs. Reovirus ds-RNA eluted in the column void 
volume fraction 20-25 and A-rich RNA was eluted in fractions 
50-70 (Fig. 4). The base-hydrolyzed poly-A eluted in the 
included volume as a large peak and only fractions 50-70 were 
selected which approximated the molecular weight of reovirus 
A-rich RNA. The poly-A fractions were pooled and desalted on 
a Sephadex G-10 column. The poly-A was lyophilized and stored 
until used.
Effect of low doses of reovirus A-rich RNA on cellular 
DNA synthesis. It has been reported that in cells infected 
with reovirus, inhibition of cellular DNA synthesis began 
6 - 8 h after infection (28,60). Subsequent reports showed that 
an inhibition of DNA synthesis could be induced by reovirus 
A-rich RNA, but this inhibition was transitory and the treated 
cells returned to normal levels of synthesis by 9 - 1 0  h after
Figure 4. Sephadex G-50 profile of reovirus RNA and hydrolyzed polyadenylic acid.
Reovirus adenine-rich RNA was used as a marker as described in Materials 
and Methods. The flow rate of the column was 30 ml/hr. Three ml fractions 
were collected. Fractions 50-70 of synthetic polyadenylic acid were 
collected, pooled and processed as described.
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treatment (32, 46). In both of the above studies reovirus 
A-rich RNA was separated from genome-ds-RNA by centrifugation 
using 5-20% sucrose density gradients. It was necessary to 
determine if similar inhibitory activities were mediated by 
reovirus A-rich RNA separated by Sephadex G-100 column chro­
matography.
Monolayer cultures of L-929 cells were treated with 
reovirus A-rich RNA at a concentration of 1 yg/ml. At timed 
intervals cultures were pulse-labelled with ^H-thymidine and 
processed as described. Figure 5 illustrates the results of 
this experiment. Inhibition of DNA synthesis began 3-4 h 
after treatment. DNA synthesis remained at minimal levels 
until 8 h and returned to control levels by 9-10 h after treat­
ment. Figure 5 shows 42% inhibition (average of values from 
4-8 h) of DNA synthesis. Under the same experimental conditions 
poly-A induced no inhibition of DNA synthesis. Treated cells 
had control levels of DNA synthesis. These results indicate 
that the A-rich RNA preparation was inhibitory for DNA 
synthesis and that poly-A had no effect on DNA synthesis.
Effect of high doses of reovirus A-rich RNA on cellular 
DNA synthesis. Since a low dose of 1 yg/ml of A-rich RNA 
caused a transient inhibition of DNA synthesis, it was possible 
that increasing the dosage of A-rich RNA could produce a more 
pronounced and sustained inhibition of DNA synthesis. DNA 
synthesis was measured in cells treated with 2 yg/ml or 
5 yg/ml of A-rich RNA. The results are shown in Figures 6 and
Figure 5. The effect of reovirus adenine-rich RNA and synthetic polyadenylic acid
on DNA synthesis in L-cells. Monolayer cultures were treated with 1.0 yg/ml ^
of reovirus A-rich RNA or oligoadenylic acid in 0.01 M Tris-HCl pH 7.2
containing 4% (w/v) sucrose. Control cultures were treated with the same
amount of buffer. At the times indicated selected cultures in duplicate
3were pulse labelled with 0.5 yCi/ml H-thymidine and processed as described 
in Materials and Methods. The radioactivity in acid-insoluble material is 
presented as counts per minute at designated intervals after treatment.
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Figure 6 . The effect of reovirus adenine-rich RNA on DNA synthesis in L-cells.
Monolayer cultures were treated with 2 yg/ml reovirus A-rich RNA and 
the control cultures were treated with equal volumes of buffer. At the 
times indicated cultures were pulse-labelled with 0.5 yCi/ml ^H-thymidine 
for 30 min. The radioactivity in acid-insoluble material is presented 
as counts per minute at specified time intervals for duplicate cultures.
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Figure 7. The effect of reovirus adenine-rich RNA on DNA synthesis in L-cells.
Monolayer cultures were treated with 5 ug/ml reovirus A-rich RNA and 
the control cultures were treated with equal volumes of buffer. At 
the times indicated cultures were pulse labelled with 0.5 yCi/ml of 
^H-thymidine for 30 min. The radioactivity in the acid-insoluble 
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7. At both concentrations inhibition began 3-4 hr after 
treatment and control levels of DNA synthesis were reached 
by 8-9 h after treatment. The maximum levels of DNA inhibition 
were 47% and 46% mean of values from 4-8 h for the 2 and 5 yg/ml 
dosages of A-rich RNA respectively. The average DNA inhibi­
tion with a low dose of 1 yg/ml was 42% (mean of values from 
4-8 h) below the control level (Fig. 5). The results showed 
that there is no significant difference in the degree and 
duration of DNA inhibition with a low (1 yg/ml) and higher 
(2 yg/ml and 5 yg/ml) doses of A-rich RNA.
Effect of multiple low doses of reovirus A-rich RNA 
on cellular DNA synthesis. Since low (1 yg/ml) and high 
(2 and 5 yg/ml) doses of A-rich RNA had an identical inhibitory 
effect on cellular DNA synthesis, sustained inhibition of DNA 
synthesis as observed in infected cells might require constant 
levels of A-rich RNA. For this reason the effect of multiple 
dosage of A-rich RNA on cellular DNA synthesis was examined. 
Monolayer cultures were treated with an initial dose of A-rich 
RNA followed by doses at 5 and 7 hours after the initial 
treatment. The times specified were selected to maintain and 
hopefully amplify inhibition levels achieved with the initial 
dose of A-rich RNA. The second dose was added at a time when 
inhibition was at its optimum i.e. 5 h after the initial 
treatment and a third dose was added when cells would have 
been recovering from the inhibition of DNA synthesis mediated 
by the initial dose of A-rich RNA.
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Monolayer cultures were treated at zero time with 
A-rich RNA (1 yg/ml) and the RNA was allowed to adsorb for 
2 h. The 2nd and 3rd doses of A-rich RNA (1 yg/ml) were 
given at 5 and 7 h after the initial treatment. At timed 
intervals,cultures were pulse-labelled with ^H-thymidine and 
samples were processed as described earlier. The cultures 
treated with a single dose of A-rich RNA showed a transient 
inhibition of DNA synthesis as described previously, but in 
cultures treated with 2 and 3 doses, DNA inhibition was 
maintained up to 10 h at maximum levels (Fig. 8). The nega­
tive slope of the lines representing 2 and 3 dose treatment 
suggests a continued progressive inhibition of DNA synthesis. 
There was no significant difference in the degree of inhibition 
of DNA synthesis at 10 h in cultures treated with 2 and 3 
doses. It was not clear why the cultures treated with 2 doses 
showed lower levels of inhibition from 5-8 h after the initial 
treatment but then decreased to a maximum (36% below the 
control) level of inhibition. During the same time period 
from 5-8 hr, cultures treated with one dose had an average 
maximum inhibition of 36% (mean of the values from 4-8 h) below 
control levels. The manipulation of cultures at 5 and 7 h 
for treatment might have some effect on this inconsistency as 
the cultures were exposed to suboptimal growth conditions 
during these times.
Effect of multiple low doses of reovirus A-rich RNA on 
cellular RNA and protein synthesis. Since, Monahan (46 ) has
Figure 8 . The effect of multiple doses of reovirus adenine-rich RNA on DNA synthesis 
in L-cells. Monolayer cultures were sequentially treated with reovirus 
A-rich RNA (1 yg/ml) at 0, 5 and 7 h. The control cultures were treated 
with equal volumes of buffer at 0, 5 and 7 hr. At the times indicated 
selected cultures were pulse-labelled with 0.5 yCi/ml of ^H-thymidine for ^  
30 min. The radioactivity in acid-insoluble material is presented as 
counts per minute for duplicate cultures at the specified time intervals.
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reported that cells treated with a single dose of A-rich RNA 
1 yg/ml had no effect on cellular RNA and protein synthesis.
It was possible that the progressive inhibition of DNA synthe­
sis by multiple doses of A-rich RNA might reflect a nonspecific 
general modification of macromolecular synthesis. It was of 
interest to determine whether repeated doses of A-rich RNA had 
any effect on the synthesis of these macromolecules.
The experimental data presented in Fig. 9 and 10 illus­
trates the effect of repeated dosage of reovirus A-rich RNA 
1 yg/ml on cellular RNA and protein synthesis respectively. No 
inhibition of RNA and protein synthesis was observed in the 
cultures treated with one, two and three doses of A-rich RNA. 
These data indicate that the reovirus A-rich RNA is capable of 
selectively inhibiting only the replicative function of 
cellular DNA and that cellular transcription and translation 
processes are not affected.
Effect of multiple high doses of reovirus A-rich RNA 
on cellular DNA synthesis. Since multiple low (1 yg/ml) doses 
of A-rich RNA mediated a sustained and progressive inhibition 
of DNA synthesis and a maximum inhibition of 50%. It was 
possible that higher multiple doses of A-rich RNA might amplify 
this inhibition.
The data presented in Figures 11 and 12 represents the 
effect of multiple high doses of 2 yg/ml of reovirus A-rich 
RNA on DNA synthesis for 10 h and 24 h respectively. Treatment 
with 2 doses resulted in a 24% inhibition of DNA synthesis
Figure 9. The effect of multiple doses of reovirus adenine-rich RNA on RNA synthesis 
in L-cells. Monolayer cultures were sequentially treated with reovirus 
A-rich RNA 1 yg/ml at 0, 5 and 7 h. The control cultures were treated 
with equal volume of buffer at 0, 5 and 7 h. At the times indicated 
selected cultures were pulse labelled with 0.5 yCi/ml ^H-uridine for 
30 minutes. The radioactivity in acid-insoluble material is presented as ^  
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Figure 10. The effect of multiple doses of reovirus adenine-rich RNA on protein
synthesis in L-cells. Monolayer cultures were sequentially treated with 
reovirus A-rich RNA 1 yg/ml at 0, 5 and 7 h. The control cultures 
were treated with equal volume of buffer at 0, 5 and 7 h. At the times 
indicated selected cultures were pulse labelled with 0.5 uci/ml of ^h -L- 
amino acid mixture for 30 min. The radioactivity in acid-insoluble 
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Figure 11. The effect of reovirus adenine-rich RNA on DNA synthesis in L-cells.
Monolayer cultures were sequentially treated with reovirus A-rich RNA 
(2 yg/ml) at 0, 5, and 7 h. The control cultures were similarly treated 
with Tris-HCl buffer. At the times indicated selected cultures were 
pulse-labelled with ^H-thymidine 0.5 yCi/ml for 30 min. The radioactivity 
in the acid-insoluble material is presented as counts per minute for 
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Figure 12. The effect of reovirus adenine-rich RNA on DNA synthesis in L-cells.
Monolayer cultures were sequentially treated with reovirus A-rich 
RNA 2 yg/ml at 0, 5 and 7 h. The control cultures were similarly 
treated with Tris-HCl buffer. At the times indicated selected cultures
3were pulse labelled with H-thymidine 0.5 yCi/ml for 30 min. The radio­
activity in the acid-insoluble material is presented as counts per 
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while 3 doses caused an inhibition of 39% of control levels 
of synthesis up to 10 h. The degree of inhibition increased 
to 38% and 50% respectively by 24 h after treatment.
Sequential treatment with three low doses (1 yg/ml) 
of A-rich RNA produced 39% (average of 9-10 h) inhibition by 
10 h (Fig. 8 ) , and the same level of inhibition was observed with 
a higher dose (2 yg/ml) of A-rich RNA under similar conditions. 
This indicated that no significant increase in the degree of 
inhibition of DNA synthesis could be achieved in cells 
treated with multiple high (2 yg/ml) doses of A-rich RNA.
These data indicated that the cells recover from 
inhibition of DNA synthesis when the inhibitory capacity of 
A-rich RNA is somehow overcome. Repeated dosage of A-rich 
RNA may mimic accumulation of viral components particularly 
the A-rich RNA which , when added exogenously, maintained 
inhibition up to 24 h after the treatment. This suggests 
that the persistant presence of A-rich RNA was essential for 
maintaining selective inhibition of cellular DNA synthesis.
Effect of synthetic polyadenylic acid on cellular DNA 
synthesis. Based on earlier work (4 6 ) it appeared that the 
heterologous oligonucleotides (5  ̂-G-terminated oligonucleotides) 
might be responsible for the inhibition of cellular DNA syn­
thesis, and that the oligoadenylate fraction had no effect 
on cellular macromolecular synthesis. To test this hypothesis, 
a sample of synthetic polyadenylic acid was prepared as 
described earlier, and the effect of this oligonucleotide
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on cellular macromolecular synthesis was examined.
Figures 5 and 13 represent the effects of a single 
low dose (1 pg/ml) and high dose (5 ug/ml) respectively. No 
alteration in the level of DNA synthesis was observed in 
treated cultures which paralleled control levels of synthesis 
up to 10 h. Treated cultures were examined microscopically and 
no cytophathology was observed.
Effect of multiple doses of synthetic polyadenylic 
acid on cellular macromolecular synthesis. A single dose of 
1 ug/ml or 5 ug/ml of poly-A had no effect on cellular DNA 
synthesis. It was also observed that repeated doses of A-rich 
RNA induced a sustained inhibition of DNA synthesis. To sub­
stantiate the hypothesis that the oligoadenylate fraction is 
not the inhibitory component of A-rich RNA, we tested the 
effect of multiple doses of poly-A on cellular macromolecular 
synthesis.
The data presented in Figures 14, 15 and 16 indicate that 
multiple doses of 1 ug/ml of poly-A caused no modification of 
Cellular DNA, RNA or protein synthesis respectively. Therefore, 
it can be assumed that the heterologous oligonucleotide frag­
ments with unique sequences might be responsible for selectively 
mediating the inhibition of cellular DNA synthesis.
Effect of Ribonucleases on the inhibitory activity of 
reovirus A-rich RNA. Based on the studies of the effect of 
synthetic oligoadenylate, it was suggested that the heterologous 
oligonucleotide fraction of the A-rich RNA may be responsible
Figure 13. The effect of synthetic polyadenylic acid on DNA synthesis in L-cells.
Monolayer cultures were treated with a single dose of synthetic poly-A 
5 yg/ml at 0 time. The control cultures were treated with Tris-HCl 
buffer, pH 7.2. At times indicated selected cultures were pulse labelled 
with ^H-thymidine 0.5 yCi/ml for 30 min. The radioactivity in the acid- 
insoluble material is presented as counts per minute for duplicate cultures. 
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Figure 14. The effect of synthetic polyadenylic acid on DNA synthesis in L-cells.
Monolayer cultures were sequentially treated with synthetic poly-A 
1 yg/ml at 0, 5 and 7 h. The control cultures were similarly treated 
with Tris-HCl buffer, pH 7.2. At the times indicated selected cultures 
were pulse labelled with ^H-thymidine 0.5 yCi/ml for 30 min. The radio­
activity in the acid-insoluble material is presented as counts per 
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Figure 15. The effect of synthetic polyadenylic acid on RNA synthesis in L-cells.
Monolayer cultures were sequentially treated with synthetic poly-A 
1 ug/ml at 0, 5 and 7 h. The control cultures were similarly treated 
with Tris-HCl buffer, pH 7.2. At the times indicated selected cultures
3were pulse labelled with H-Uridine 0.5 u^i/ml for 30 min. The radio- mc\
activity in the acid-insoluble material is presented as counts per 
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Figure 16. The effect of synthetic polyadenylic acid on protein synthesis in L-cells.
Monolayer cultures were sequentially treated with synthetic poly-A 1 pg/ml 
at Of 5 and 7 h. The control cultures were similarly treated with Tris- 
HCl buffer. At the times indicated selected cultures were pulse labelled 
with ^H“L-amino acids 0.5 yCi/ml for 30 min. The radioactivity in the 
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for inhibiting DNA synthesis. To more accurately assess this 
possibility, the effect of various specific endoribonucleases and 
exoribonucleases on the inhibitory activity of A-rich RNA was 
examined. Specific endoribonucleases were chosen to cleave 
the heterologous oligonucleotides at specific nucleotide 
locations and exoribonucleases were used to degrade the olig- 
nucleotides to mononucleotides in an attempt to render the 
A-rich RNA biologically inactive.
The purified active reovirus A-rich RNA preparation was 
treated with ribonucleases. Ribonuclease-treated-A-rich RNA 
2 yg/ml was used to sequentially treat monolayer cultures 
at 0, 5 and 7 h. Control cultures were similarly treated with 
Tris-HCl buffer and with the specific buffer system plus the 
enzyme used in each enzymatic hydrolysis. The results of the 
experiments are shown in Table 1. The ribonuclease, venom 
phosphodiesterase, N^ and T^-treated reovirus A-rich RNA did 
not mediate an inhibition of DNA synthesis whereas A-rich RNA 
treated with T2 and Pancreatic ribonuclease could inhibit DNA 
synthesis. These results indicated that the oligonucleotide 
fragment(s) capable of mediating an inhibition of DNA synthe­
sis were hydrolyzed by the venom phosphodiestrase, N̂  ̂ and T^, 
but were not degraded by T 2 and pancreatic ribonuclease enzymes.
The venom phosphodiesterase is a non-specific exoribo- 
nuclease and hydrolyses RNA to 5 ^-monophosphates starting from 
the 3'*-0H end. All the ss-oligonucleotides terminate with a 
3'‘-OH end, this OH group is specifically required for the
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Table 1. Inhibition of DNA synthesis in L-cells treated with 
reovirus A-rich RNA hydrolyzed with ribonucleases. 
Reovirus A-rich RNA was treated with each enzyme and 
the reaction conditions are described in Materials 
and Methods. Monolayer cultures were treated sequen­
tially with ribonuclease-treated A-rich RNA 2 yg/ml 
at 0, 5 and 7 h. The control cultures were similarly 
treated with equal volumes of Tris-HCl buffer, pH 7.2 
containing 4% (w/v) sucrose, and specific hydrolysis 
buffer system plus the enzyme. DNA synthesis was 









^ 1 3 "-GMP -
3"-GMP -
?2 ' 3"-AMP +
Pancreatic ribionuclease C-3"Py
(+): DNA synthesis inhibited.
(-): DNA synthesis not inhibited.
1 : Requires a free 3'-0H group and liberated nucleoside-5^-
phosphate in a stepwise manner.
2 : Preferetially attacks Ap residues and releases 3^-mono-
phophates, but eventually all phosphodiester bonds are 
broken.
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action of venom phosphodiesterase. The results indicated that 
A-rich RNA may have been completely degraded to mononucleotides 
resulting in the loss of its inhibitory properties.
The ribonucleases N^ and T^, both specifically hydrolyze 
between 3^-GMP and the 5 ''-OH group of the adjacent nucleotide 
of an RNA chain. Approximately 2000 of the heterologous oligo­
nucleotides in A-rich RNA have 5 '-guanosine (10,48,65). This 
nucleotide would be cleaved by both the ribonucleases N^ and T^. 
The results indicated that the presence of guanosine at the 
5 ■'end of these nucleotides was critical for the inhibitory 
action for DNA synthesis.
Pancreatic ribonuclease is a specific endonuclease which 
splits the bond between the phosphate residue at C-3' in a 
pyrimidine nucleotide to C-5 ' of the next nucleotide in the 
sequence. Since the enzyme had no effect on the inhibitory 
activity of A-rich RNA, it may be assumed that pancreatic 
ribonuclease did not degrade the specific fractions of A-rich 
RNA which were responsible for mediating the inhibition of DNA 
synthesis. It has been reported that pancreatic ribonuclease 
does not readily attack an ApA linkage (34), particularly when 
they are present in polymers of short chain length (5 ), and it 
has also been reported that reovirus A-rich RNA was not degraded 
by the enzyme (58) . The purine 3'->- 5'-pyrimidine phosphodiester 
bond and the adjacent purine - purine bonds represented by 
Pu-p-Pu-p-Py-p are strongly resistant to the action of pancreatic 
ribonuclease ( 5 ). Based on our experimental data and the
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reports on the properties of this enzyme, it can be assumed 
that the heterologous oligonucleotide fraction of A-rich RNA 
was not degraded and retained its inhibitory activity.
Ribonuclease T2 , preferentially attacks Ap residues and 
eventually cleaves the RNA chain non-specifically at all phos­
phodiester bonds. There are 2 60 molecules with a chain length 
of 5-9 nucleotides in the heterologous oligonucleotide fraction 
of A-rich RNA which have Ap residues in their structure (48). 
According to the documented activity of the enzyme, all fractions 
of the A-rich RNA should have been degraded and the inhibitory 
activity should have been lost. Since A-rich RNA was active 
even after treatment with Tg/ it is possible that the short 
chain heterologous oligonucleotides with a maximum chain length 
of up to 9 residues were not degraded. Thus, a restriction of 
hydrolytic activity similar to that described earlier for pan­
creatic ribonuclease may be taking place.
Viability of Cells. It was necessary to exclude the 
possibility that the inhibition of DNA synthesis by A-rich RNA 
was a specific event and not the indirect result of cytopathic 
effect of cell death. During the studies of reovirus A-rich 
RNA inhibition, cultures were routinely monitored microscopically 
for cytopathologic changes. No visible change in. the appear­
ance of cells was noted. To more accurately assess cytopatho- 
logical changes cultures were also examined for any loss in 
cell viability by trypan blue exclusion. Monolayer cultures 
were treated with three doses of 2 yg/ml of A-rich RNA. At
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timed intervals cultures were stained with 0.4% (w/v) trypan 
blue as described in Materials and Methods. The stained cul­
tures were examined microscopically and the results are 
presented in Fig. 17. No significant decrease in cell viability 
was noted up to 12 h after treatment with A-rich RNA.
Figure 17. Viability of L-cells treated with reovirus adenine-rich RNA. Monolayer 
cultures were sequentially treated with reovirus A-rich RNA 2 yg/ml at 
0, 5 and 7 h. At the times indicated selected cultures were stained with 
trypan blue, and total and nonviable cells were counted. Viability is 
expressed as percent of control.






The efficiency of inhibition of cellular DNA synthesis 
has been shown to be directly related to the multiplicity of 
infection of infectious and UV-inactivated virus particles (60). 
Inhibition by non-infectious particles (UV-inactivated) could 
not be accounted for by multiplicity reactivation and subse­
quent replication of virus (32). In addition, it has been 
shown in studies with UV-inactivated particles (60) and tempera­
ture-sensitive mutants (26) of reovirus that completion of the 
viral replicative cycle, terminating in progeny virus produc­
tion and cell lysis, is not necessary for the inhibition of 
DNA synthesis. These observations suggested that an input 
component(s) of the reovirion and/or a transcription product(s) 
might be responsible for the inhibition. Attempts have been 
made using infectious and non-infectious subviral particles 
(SVP^) to identify the viral component which could mediate 
this inhibition (17). This study indicated that reovirus cores 
(inner capsid shell and genome ds-RNA) and top component (empty 
capsids) had no inhibitory effect on DNA synthesis. However, 
a delayed inhibition of DNA synthesis was observed in SVP^-
infected cells. Top component did not inhibit the synthesis
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of DNA even though it contains all virion polypeptides.
However, it is missing 60% of the virion A-rich RNA. This 
suggested that the delay in the inhibition of DNA synthesis 
might have been the result of lack of release of single­
stranded oligonucleotides from the input SVP^ particles. The 
time of first appearance of reovirus adenine-rich oligonucleo­
tides during virus replication coincides with the beginning of 
the inhibition of DNA synthesis (8). This provided additional 
indirect evidence that A-rich RNA might be the inhibitory 
principle produced during reovirus infection.
Monahan has shown that purified reovirus A-rich RNA 
was efficiently taken up by cells in monolayer culture, and 
that it was the only viral component tested which was capable 
of mediating a selective but transient inhibition of DNA 
synthesis (46). In our experiments a single does of reovirus 
A-rich RNA lyg/ml produced an inhibition pattern similar to 
that reported by others (32,46).
Since the inhibition of DNA synthesis has been shown to 
be a dose-dependent phenomonen, it suggested that the increased 
efficiency of inhibition due to high input multiplicities may 
be due to release of greater quantities of A-rich RNA during 
the early stages of infection. Maintenance of the increased 
rate and degree of inhibition later in infection could be the 
result of the production of higher yields of progeny virus 
which in turn would synthesize increased quantities of A-rich 
RNA.
70
The higher particle to cell ratio of UV-inactivated 
virus has been shown to be as effective in inhibiting DNA 
synthesis as infectious reovirions. UV-inactivated reovirions 
have been shown to be capable of limited transcription even 
though the genome is damaged. Initial characterization of the 
transcription product indicated that it was A-rich RNA (32). 
This information strongly indicates an apparent necessity for 
the contribution of a virion component, possibly A-rich RNA, 
from the input particle for mediating the initial inhibition of 
DNA synthesis. Sustained inhibition of DNA synthesis could be 
the result of the production of a new transcription component, 
possibly A-rich RNA, but not the replication of complete 
infectious progeny virions.
Data reported in this dissertation support the concept 
that initial inhibition is mediated by input A-rich RNA. Con­
tinued production of A-rich RNA is necessary for maintenance of 
inhibition. No significant increase in the level of inhibition 
was observed with an increased single dose of 5 yg/ml of reo­
virus A-rich RNA. It appeared that sites for the inhibitory 
action of A-rich RNA were saturated with a specific amount of 
the A-rich RNA and the remaining amount of A-rich RNA had no 
added effect on the inhibition of DNA synthesis. Quantities 
smaller than 1 yg/ml of A-rich RNA might give a minimum dose 
level for the inhibition of DNA synthesis, but this was not 
tested.
In an asynchronous culture, cells will be passing 
through different phases of the cell cycle, and only a fraction
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of the population be in S phase at any given time. It has 
been reported that initiation of the synthesis of DNA upon 
new regions of chromosomal DNA is blocked after reovirus 
infection (23,24), but DNA chain growth is not altered (31).
In a subsequent vitro study with purified A-rich RNA and 
isolated nuclei it was demonstrated that A-rich RNA causes an 
inhibition of cellular DNA synthesis possibly by interfering 
with the cytoplasmic factor(s) necessary for initiation of DNA 
synthesis (46). This implies that, although the A-rich RNA 
is efficiently taken up by the cells (46), inhibition of DNA 
synthesis will take place only in those regions of the 
chromosome where new sites are being initiated for DNA synthesis. 
The sites which were initiated before contact with A-rich RNA 
should proceed and complete DNA synthesis. This may explain 
the transitory nature of inhibition with one dose of A-rich 
RNA since the A-rich RNA may be modified before new initiation 
events occur. This inhibition seems to be highly specific for 
specific initiation events and/or factors since activity of 
nuclear and cytoplasmic DNA polymerases and the DNA template 
are not altered even after inhibition of DNA has started (4,60).
It was mentioned earlier that sustained inhibition of 
DNA synthesis in reovirus-infected cells may be the result of 
A-rich RNA synthesized by progeny viral particles or input 
particle transcription during later parts of viral replication.
In either Ccse, a continuing supply of A-rich RNA is assured. To 
mimic such natural infection conditions, cultures were inoculated
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sequentially with three doses of reovirus A-rich RNA. One 
dose produced a transient inhibition, but a persistent and 
progressive inhibition was mediated by 2 and 3 doses (Fig. 8).
In addition multiple higher doses of A-rich RNA produced 
identical levels of inhibition. This indicated that the persis­
tent presence of A-rich RNA was essential for maintaining the 
inhibition of cellular DNA synthesis. The optimum inhibitory 
concentration of A-rich RNA or the proper sequence of doses 
was not completely defined since total inhibition of DNA 
synthesis was not achieved by these procedures. The effect of 
multiple doses of A-rich RNA was selective only for the 
replicative function of DNA since these doses had no effect 
on cellular RNA and protein synthesis.
The half life of A-rich RNA in treated cells seems 
to be very short since a single high dose of A-rich RNA (5 yg/ml) 
mediated only a transitory inhibition even though the dosage was 
higher than the combined amount of 3 doses (3 yg) that mediated 
a sustained and progressive inhibition up to 10 h. It appeared 
that after an optimum quantity of A-rich RNA was utilized for 
mediating the inhibition of DNA synthesis the remaining RNA was 
degraded or modified within the cell before it could affect new 
DNA initiation events on the chromosome.
It was proposed earlier that the heterologous oligonu­
cleotide fraction of A-rich RNA may be responsible for mediating 
the inhibition of DNA synthesis and that the oligoadenylate 
fraction has no inhibitory effect. To test this hypothesis the
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effect of single low and high and multiple high doses of syn­
thetic poly-A with molecular weight similar to A-rich RNA was 
examined. No alteration in the levels of cellular DNA, RNA or 
protein synthesis was observed. These results agree with those 
of Monahan (46) , and indicated that DNA synthesis inhibition 
was not the result of non-specific inhibition by oligonu­
cleotides of a certain molecular weight or size, or oligo­
adenylate nucleotide content, but the result of the specific 
action of one or more heterologous oligonucleotide with unique 
chemical or physical characteristics. However, it is not 
certain that reovirus A-rich oligoadenylate will have the 
same biological activity as synthetic oligoadenylate since the 
synthetic oligonucleotides did not have the 5 ■'-terminus pppA— , 
which might have some function in the inhibition process.
The effect of different exo- and endo-ribonucleases on 
the inhibitory activity of A-rich RNA was examined in an attempt 
to provide additional support to the hypothesis that a specific 
class of A-rich RNA oligonucleotides might be specifically 
inhibitory. The results indicated that A-rich RNA treated with 
ribonuclease N^, T^ and venom phosphodiesterase lost its inhibi­
tory potential. T^ and pancreatic ribonuclease had no effect 
on this activity. The N^ and T^ nucleases are known to 
specifically cleave only the guanosine residue in an RNA chain 
and the venom phosphodiesterase hydrolyzes RNA to mononucleo­
tides. It has been reported that nearly all of the heterologous 
oligonucleotides possess guanosine at the 5 '  -terminus (48). This 
information leads us to suggest that inhibition of DNA synthesis
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was the result of intact unique heterologous oligonucleotide 
fragments. In addition it indicates that the presence of 
guanosine at the 5^-termini of the oligonucleotides may be 
critical for the inhibitory action of A-rich RNA.
Thus, we know that in reovirus-infected cells the first 
detectable change in cellular metabolism is the specific inhi­
bition of DNA synthesis. Detectable changes in RNA and protein 
synthesis occur only during the later stages of virus replica­
tion and are followed shortly by severe cytopathology and 
cell death. The initial phases of the inhibition of DNA 
synthesis appear to be specific events related to reovirus 
infection and experimental data in this and other studies 
indicate that this inhibition of DNA synthesis may be caused 
by reovirus A-rich RNA. However, in infected cells it is 
extremely difficult to distinguish between the specific 
inhibition of DNA synthesis mediated by reovirus replication 
and non-specific inhibition of macromolecular function late 
in infection resulting from cell necrosis. The experimental 
data presented here suggest that multiple doses of reovirus 
A-rich RNA are capable of selectively mediating a sustained 
and progressive inhibition of DNA synthesis up to 24 h but 
have no effect on RNA and protein synthesis or cell viability. 
In this case selective inhibition of DNA function can be 
caused by a specific virion component and replication product 
and its effects can be studied without obscuration by non­
specific events related to the development of cytopathology.
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In this study an indirect approach was used to charac­
terize the inhibitory fraction of A-rich RNA. A-rich RNA can 
be fractionated by DEAjl-cellulose chromatography into specific 
molecular fractions, and the inhibitory activity of these 
fractions could be determined. The effect of the active 
fractions on the events in the initiation of DNA synthesis 
should provide information which could elucidate the mechanism 
of action of reovirus A-rich RNA. Since A-rich RNA is taken 
up very efficiently by the cell, a study of its localization 
in cell and the condition of the active fraction after locali­
zation, could provide information regarding the specific 
cellular sites of inhibitory activity.
It is known that initiation of DNA starts with the 
synthesis of an RNA priming fragment. Since reovirus A-rich 
RNA may inhibit initiation of DNA synthesis by interfering with 
cytoplasmic initiation factor(s) vitro, it is possible that 
it may have a similar activity iui vivo. The chemical and 
structural characteristics of A-rich RNA suggest its potential 
to interfere with RNA-mediated initiation of DNA synthesis.
It has been reported that normal diploid and transformed 
human cells have different sensitivities to reovirus infection 
and that DNA synthesis was inhibited in transformed cells and 
not in normal cells (21). It will be of interest to study 
the effects of purified A-rich RNA on normal diploid and trans­
formed cells to determine if differences exist in the sensiti­
vity of the regulation of DNA replication in the two types of
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cells. If only transformed cells are sensitive to the action 
of A-rich RNA, it could provide an effective means of character­
izing fundamental differences in the regulatory properties of 
normal and cancer cells.
CHAPTER V
SUMMARY
This study of the effect of reovirus adenine-rich 
(A-rich) RNA on DNA synthesis in L-cells suggests that a single 
dose of A-rich RNA mediates a transitory but selective inhibi­
tion of DNA synthesis. Multiple doses of A-rich RNA which 
produce a sustained and progressive inhibition of DNA synthesis, 
have no effect on cellular RNA or protein synthesis, and the 
treated cells show no cytopathology or cell death. High single 
and multiple doses of A-rich RNA do not increase the rate or 
degree of inhibition of DNA synthesis.
Single and multiple doses of synthetic oligoadenylic 
acid (poly-A) at low and high concentrations have no effect on 
cellular DNA, RNA or protein synthesis. This suggests that 
the oligoadenylate fraction of A-rich RNA is not inhibitory 
for DNA synthesis.
The effects of specific endo- and exo-ribonucleases 
on the inhibitory activity of A-rich RNA were examined. While 
ribonucleases N̂ ,̂ T^ and venom phosphodiesterase destroyed the 
inhibitory activity of A-rich RNA, pancreatic and Tg ribo­
nuclease did not. This indicates that A-rich RNA is rendered
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biologically inactive when heterologous oligonucleotides 
are either deprived of 5^-G termini or completely degraded 
to mononucleotides. These data support the hypothesis that 
the inhibitory effect is not mediated by the oligoadenylate 
fractions of A-rich RNA, but by the specific activity of one 
or more heterologous oligonucleotides.
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